Stonington, CT, United States of America

Ronald P Gladue

This inventor holds 15 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Pfizer Corporation, Amgen Fremont Inc., Bristol-Myers Squibb Compnay. Active years: 2003-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald P Gladue. Retrieved from https://idiyas.com/inventor/ronald-p-gladue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 7)

% Patents Active = 73.3

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 6.9

ph-index = 10

Forward Citations = 420(Granted Patents)

Company Filing History:

Bristol-Myers Squibb Compnay

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2019

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10196452 - Binding molecules to the human OX40 receptor (2019-02-05),

2. 9840562 - Binding molecules to the human OX40 receptor (2017-12-12),

3. 9238691 - Nucleic acids encoding antibodies to CCR2 (2016-01-19),

4. 9028824 - Binding molecules to the human OX40 receptor (2015-05-12),

5. 8710191 - Antibodies to CCR2 (2014-04-29),

6. 8388971 - Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses (2013-03-05),

7. 8236930 - Binding molecules to the human OX40 receptor (2012-08-07),

8. 7960515 - Binding molecules to the human OX40 receptor (2011-06-14),

9. 7626012 - Nucleic acid molecules which encode antibodies that bind CD40 (2009-12-01),

10. 7618633 - Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses (2009-11-17),

11. 7563442 - Antibodies to CD40 and methods of treating cancer and enhancing immune responses (2009-07-21),

12. 7338660 - Methods of treating cancer and enhancing immune responses with antibodies that bind CD40 (2008-03-04),

13. 7288251 - Antibodies to CD40 (2007-10-30),

14. 6878522 - Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 (2005-04-12),

15. 6649611 - Piperazine derivatives (2003-11-18),

Title: Inventor Ronald P Gladue - Revolutionizing Technology

Introduction: Ronald P Gladue, a distinguished inventor hailing from Stonington, CT (US), is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Ronald P Gladue holds several patents in the realm of artificial intelligence, robotics, and renewable energy sources, showcasing his innovative prowess and forward-thinking mindset.

Career Highlights: With a career spanning over two decades, Ronald P Gladue has worked with leading tech companies, spearheading projects that have redefined industry standards and pushed the boundaries of technological advancements.

Collaborations: Throughout his career, Ronald P Gladue has collaborated with top researchers, engineers, and scientists, fostering a culture of innovation and knowledge-sharing that has led to remarkable breakthroughs in various technological domains.

Conclusion: In conclusion, Ronald P Gladue stands as a visionary inventor whose relentless pursuit of innovation continues to inspire the next generation of technologists and engineers.

Profile summary based on public USPTO records.